1 / 12

Life Span After Bone Marrow Transplant

Visit here to learn more about bone marrow transplant: https://www.edhacare.com/treatments/organ-transplant/bone-marrow <br><br>Life expectancy after a Bone marrow transplant improves over time but is still lower than the general population. Risk is highest shortly after transplant, then decreases. Survival at 20 years is 80.4%. The main causes of death include disease relapse, infections, GvHD, second malignancies, and cardiovascular diseases. Risk factors for late death include age at transplant, donor type, male sex, and secondary myelofibrosis. Long-term survivors require screening for complicat

olivia226
Download Presentation

Life Span After Bone Marrow Transplant

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Life Span After Bone Marrow Transplant Website:: https://www.edhacare.com/ Email:: care@edhacare.com

  2. Table Of Content • Introduction • Factors Influencing Survival • Survival Rates • Long-Term Challenges • Advances in Medical Care • Patient Care and Lifestyle • Real-World Perspectives • Conclusion https://www.edhacare.com/treatments/organ-transplant/bone-marrow

  3. Introduction What is a bone marrow transplant (BMT)? Bone marrow transplant replaces damaged marrow with healthy cells to treat cancers, genetic disorders, and immune deficiencies by harvesting, conditioning, and infusing stem cells. Different transplant types include autologous (patient's own stem cells), allogeneic (donor stem cells requiring HLA matching and carrying higher complications risk), and umbilical cord (for patients without a matching donor). Why Discuss Life Span After BMT? Patients and families worry about survival, quality of life, and cure potential, gaining insight into the journey's risks and hopeful outcomes. https://www.edhacare.com/treatments/organ-transplant/bone-marrow

  4. Factors Influencing Survival 1. Underlying Disease Treatment outcomes vary: Acute leukemias benefit from early BMT. Chronic leukemias may have lower survival rates. Success high with matched donors for aplastic anemia. Early transplants improve survival in inherited disorders. 2. Donor Match Quality Close HLA matches lower rejection risks. Siblings offer optimal matches. Haploidentical or cord blood are alternatives if no full match. https://www.edhacare.com/treatments/organ-transplant/bone-marrow

  5. Factors Influencing Survival 3. Type of Transplant Autologous transplants have lower rejection risks, while allogeneic transplants can cure leukemia but come with higher complication risks and require an HLA-matched donor. 4. Patient Age and General Health Younger patients generally have higher survival rates due to stronger immune systems, while older patients face increased risks from therapy and pre-existing conditions. 5. Post-Transplant Care Follow-up care for infections, GVHD, and complications is crucial, with improved outcomes from advanced treatments and support facilities. https://www.edhacare.com/treatments/organ-transplant/bone-marrow

  6. Survival Rates After BMT Short-Term Survival Rates 1-year survival rates for autologous transplants range from 80% to 90%, while allogeneic transplants show rates between 60% and 85%, affected by donor match and patient condition. Long-Term Survival Rates Autologous: 50–80% survival; Allogeneic: 40–70% (dependent on factors like GVHD). Better outcomes for early-stage leukemias, lymphomas, and non-malignant conditions; lower survival for advanced cancers or relapses. https://www.edhacare.com/treatments/organ-transplant/bone-marrow

  7. Survival Rates After BMT Survival Trends by Disease For acute leukemias, higher survival in remission transplants. Autologous transplants benefit lymphomas, particularly Hodgkin’s disease. Early intervention in inherited disorders boosts survival rates. Factors Affecting Survival Rates Complications include chronic GVHD and infection risks. Advances in treatment focus on improved regimens and donor matching technologies. https://www.edhacare.com/treatments/organ-transplant/bone-marrow

  8. Long-Term Challenges Chronic graft-versus-host disease (GVHD):A condition where the donor stem cells attack the recipient's body. Symptoms include skin rashes, diarrhea, ulcers, and weight loss. Infections:Patients may be at a higher risk of infections for months or years after the transplant. Organ dysfunction:GVHD, previous infections, or chemotherapy can cause lung disease. Patients may experience long-term effects in Kidney and liver. Bone, joint, and dental problems:Patients may develop osteoporosis or ovarian failure. Psychological issues:Patients may experience difficulty with reading, memory, and attention. Some patients may experience post-traumatic stress disorder, anxiety or depression due to physical limitations. Other challenges can also arise like hormone problems, infertility, cataracts, chronic fatigue, insomnia, and sexual difficulties. https://www.edhacare.com/treatments/organ-transplant/bone-marrow

  9. Advances in Medical Care • Chimeric antigen receptor-T cell (CAR-T cell) therapy: An immunotherapy treatment that has been effective in treating blood disorders like leukemia, lymphoma, and multiple myeloma • In vivo monoclonal antibodies: These include CAMPATH 1G and anti-LFA-1 (CD11a) • Eculizumab treatment: This treatment increases the overall survival rate for patients with classical PNH • New techniques in donor matching. • Improved post-transplant care (e.g., infection prevention, GVHD treatments). • Innovations in conditioning therapies (less toxic regimens). https://www.edhacare.com/treatments/organ-transplant/bone-marrow

  10. Patient Care and Lifestyle Infection prevention: Avoid contact with germs until your immune system is working again. Practice safe eating and drinking. Don't eat raw meat, fish, or vegetables. Make sure your water is safe Diet: Eat a well-balanced diet, avoid acidic or tart foods, strong spices, and coarse foods. Avoid alcoholic beverages and mouthwashes with alcohol. A dietitian can help with dietary and nutritional problems. Exercise: Gradually increase physical activity to strengthen bones and muscles, and improve endurance. Exercise regularly to maintain a healthy weight and heart Checkups: Continue to get regular checkups, even if you feel well. https://www.edhacare.com/treatments/organ-transplant/bone-marrow

  11. Conclusion Bone Marrow Transplants Save Lives. It effective for treating life-threatening conditions like leukemia, lymphoma, and inherited disorders. This can offer a cure for many patients, especially with early intervention. Survival rates depend on disease type, patient health, donor match, and post-transplant care. Many patients achieve long-term survival and good quality of life. Complications like graft-versus-host disease (GVHD) and infections can impact outcomes. Long-term monitoring and lifestyle adjustments are essential for success. Improved techniques in donor matching and conditioning regimens. New therapies to manage complications like chronic GVHD. Research continues to improve outcomes and reduce risks. Patients, families, caregivers, and medical teams must work together to optimize outcomes. Importance of psychological and emotional support throughout the journey. “A bone marrow transplant is not just a treatment—it’s a second chance at life.” https://www.edhacare.com/treatments/organ-transplant/bone-marrow

  12. https://www.edhacare.com/treatments/organ-transplant/bone-marrowhttps://www.edhacare.com/treatments/organ-transplant/bone-marrow

More Related